Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Co-funded partnership · Running

ERA4Health Fostering a European Research Area for Health Research

Coordinator
Instituto De Salud Carlos Iii, Spain
Runs
1 November 2022 to 30 June 2034
Status
Running
EU funding
€102.6m
Total cost
€342.0m
Partners
60 organisations in 27 countries
Type
Co-funded partnership
Grant agreement
101095426

What the project is doing

In the project's own words, from its summary on CORDIS.

Excellent EU programs push health R&I but are not sufficient. Synergy with strategic initiatives in MS and a new model for impactful collaborations are needed to address the challenges for health. ERA4Health brings the opportunity to increase EU transnational collaborative research funding by creating a funding body for joint programming in priority areas addressing EU Public Health Needs, with total duration of 12 years.

The main ambition of the partnership it is the contribution to the goal of Europe to be at the forefront of science and innovation in Health Research by 2050 and enhancing the biomedical research to provide a better health for citizens, not only in Europe but at international level. ERA4Health focuses on tackling diseases and reducing disease burden and the following challenges: 1) the increasing demand for a better quality of life and a better care of patients, 2) the need to transform public health care systems in more effective, efficient, equitable, accessible, and resilient ones and 3) the need to strengthen disease prevention and health promotion.

In this view, ERA4Health objectives are: .SO1- Support relevant medical research including clinical fields and intervention areas (prevention, diagnosis, treatment) .SO2- Improve the utilisation of existing health technologies in clinical practice .SO3- Build capacity, in particular in conducting Investigator Initiated Clinical Studies at EU scale. SO4- Implement and advance the practice of RRI across the breadth of the programmeERA4Heatlth will be implemented in 2 phases:.

Phase 1 (3 years) will implement joint calls focused on nutrition and lifestyle-related diseases, cardiovascular diseases and nanomedicine (4 calls in the first 2 years). In parallel, it will establish a supporting framework to overcome the challenges in launching international IICSs joint calls. . Phase 2 (9 years): after the EC approval, additional multinational calls for IICSs and joint calls for other priority areas will be launched in accordance with the decision of the Health Programme Committee taken at the end of previous Phase 1.

This Phase 2 of the Partnership will continue supporting relevant medical research and new knowledge generation in the research priority areas stablished in the ERA4Health long-term Strategic Research and Innovation Agenda (SRIA), with a particular focus devoted to support and fund multi-country Investigator-Initiated Clinical Studies (IICS). The research priority areas included in the SRIA are: nutrition and life-style related diseases, prevention and public health strategies, cardiovascular diseases, nano and advanced technologies for disease prevention, diagnostic and therapy.

ERA4Health will fund non-commercial multi-country IICS to enhance this impactful and added value clinical research. The additional activities in ERA4Health Phase 2 will serve to provide support and building capacity in conducting multi-country IICSs and to overcome the identified challenges and obstacles in these type of IICSs.34 partners (20 from EU, 3 Third Countries associated to HE and 2 non-associated, non EU), will commit 90,510,000€, during the 3 first years, as financial support to third parties.10 new partners, mainly funders of multi-country Investigator-Initiated Clinical Studies, are added to the ERA4Health consortium in its Phase 2.

In total, 47 partners from 27 countries will be included in the ERA4Health consortium, with additional financial support to third parties in Phase 2 (186,150,000.00 €).

Topics

Who is involved

OrganisationCityCountryRole
Instituto De Salud Carlos IiiMadridSpainCoordinator
Bundesministerium Fur BildungWienAustriaParticipant
Fonds Zur Förderung Der Wissenschaftlichen ForschungWienAustriaParticipant
Centre Federal D'expertise Des Soins De SanteBruxelles / BrusselBelgiumParticipant
Eigen Vermogen Van Het Instituut Voor Landbouw- En VisserijonderzoekMerelbekeBelgiumParticipant
Fonds De La Recherche Scientifique- FnrsBruxelles / BrusselBelgiumParticipant
Fonds Voor Wetenschappelijk Onderzoek-VlaanderenBruxelles / BrusselBelgiumParticipant
Agentura Pro Zdravotnicky Vyzkum Ceske Republiky Azv CrPrahaCzechiaThird party
Ministerstvo Zdravotnictvi Ceske RepublikyPrahaCzechiaParticipant
Masarykova univerzitaBrnoCzechiaThird party
Deutsches Zentrum Fur Luft - Und Raumfahrt eVKolnGermanyParticipant
Kks-Netzwerk eV -Netzwerk Der Koordinierungszentren Fur Klinische StudienBerlinGermanyThird party
Universitaetsklinikum FreiburgFreiburgGermanyThird party
InnovationsfondenKobenhavn KDenmarkParticipant
Sihtasutus Eesti TeadusagentuurTartuEstoniaParticipant
Academy of Scientific Research and Technology AsrtCairoEgyptParticipant
Geniki Grammatia Erevnas Kai KainotomiasAthensGreeceParticipant
Agencia De Ciencia Competitividad Empresarial E Innovacion AsturianaLlanera AsturiasSpainParticipant
Agencia Estatal De InvestigacionMadridSpainParticipant
Consejeria De Presidencia, Sanidad Y Emergencias De La Junta De AndaluciaSevillaSpainParticipant
Departament De Salut - Generalitat De CatalunyaBarcelonaSpainParticipant
Fundacion Para El Fomento En Asturias De La Investigacion Cientifica Y La TecnologiaLlaneraSpainParticipant
Fundacion Para La Investigacion Biomedica Del Hospital Universiatrio La PazMadridSpainThird party
Fundacion Para La Investigacion De Malaga En Biomedicina Y SaludMalagaSpainThird party
Fundacion Publica Andaluza Progreso Y Salud M.p.SevillaSpainThird party
Servicio Madrileno De SaludMadridSpainThird party
Agence Nationale De La RechercheParisFranceParticipant
Ecrin European Clinical Research Infrastructure NetworkParisFranceParticipant
European Technology Platform on Nanomedecine EtpnParisFranceParticipant
Ministre De La Sante Et De L'acces Aux SoinsParisFranceParticipant
Nemzeti Kutatasi Fejlesztesi Es Innovacios HivatalBudapestHungaryParticipant
The Health Research BoardDublinIrelandParticipant
University College Cork - National University of Ireland, CorkCorkIrelandThird party
Ministry of HealthJerusalemIsraelParticipant
Fondazione Regionale per La Ricerca BiomedicaMilanoItalyParticipant
Istituto Superiore Di SanitaRomaItalyThird party
Ministero Dell'universita E Della RicercaRomaItalyParticipant
Ministero Della SaluteRomaItalyParticipant
Lietuvos mokslo tarybaVilniusLithuaniaParticipant
Latvijas Zinatnes PadomeRigaLatviaParticipant
Eatris EricAmsterdamNetherlandsParticipant
Nederlandse Organisatie Voor Wetenschappelijk OnderzoekDen HaagNetherlandsParticipant
Zorgonderzoek Nederland ZonDen HaagNetherlandsParticipant
Helse Bergen HfBergenNorwayThird party
Norges ForskningsradOsloNorwayParticipant
Narodowe Centrum Badan I RozwojuWarszawaPolandParticipant
Aibili Associacao Para Investigacao Biomedica E Innovacao Em Luz E ImagemCoimbraPortugalThird party
Aicib - Agencia De Investigacao Clinica E Inovacao BiomedicaPortoPortugalParticipant
Fundacao Para a Ciencia E a TecnologiaLisboaPortugalParticipant
Unitatea Executiva Pentru Finantarea Invatamantului Superior a Cercetarii Dezvoltarii Si InovariiBucurestiRomaniaParticipant
Vetenskapsradet - Swedish Research CouncilStockholmSwedenParticipant
Biomedicinske Centrum Slovenskej Akademie Vied, Verejna Vyskumna InstituciaBratislavaSlovakiaParticipant
Centrum Vedecko Technickych Informacii Slovenskej RepublikyBratislavaSlovakiaParticipant
Slovenska Akademia ViedBratislavaSlovakiaParticipant
Univerzita Pavla Jozefa Safarika V KosiciachKosiceSlovakiaThird party
Turkiye Bilimsel Ve Teknolojik Arastirma KurumuAnkaraTürkiyeParticipant
Turkiye Saglik Enstituleri BaskanligiIstanbulTürkiyeParticipant
National Science and Technology CouncilTaipeiTWAssociatedpartner
Department of HealthLeedsUnited KingdomParticipant
Breakthrough T1dNew YorkUnited StatesParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI